Unlocking The Potential of NKIRAS2: A Protein with Multiple Functions and Potential Drug Targets

Target Name: NKIRAS2

NCBI ID: G28511

NKIRAS2

Unlocking The Potential of NKIRAS2: A Protein with Multiple Functions and Potential Drug Targets

NKIRAS2 (KappaB-Ras2) is a protein that is expressed in various tissues throughout the body, including the brain. It is a key regulator of the nervous system and has been implicated in a number of neurological and psychiatric disorders. Despite its importance, little is known about NKIRAS2 and its potential as a drug target or biomarker.

The NKIRAS2 gene was identified in the late 1990s as a potential candidate for a protein kinase that could regulate the activity of the transcription factor KappaB (KB). This was based on the fact that NKIRAS2 contains a highly conserved catalytic domain that is commonly found in Kinase proteins, as well as a unique N-terminus that is involved in protein-protein interactions.

Since its identification, NKIRAS2 has been extensively studied to determine its function in various cellular processes, including cell signaling, DNA replication, and stress response. These studies have led to a number of interesting findings. For example, NKIRAS2 has been shown to play a role in the regulation of cell proliferation, by inhibiting the activity of the oncogene transforming growth factor-尾 (TGF-β).

In addition to its role in cell signaling, NKIRAS2 has also been shown to be involved in the regulation of the nervous system. For example, it has been shown to play a role in the development and maintenance of neural stem cells, by regulating the production of dial-binding transcription factor-beta (BDNF) and nestin.

Despite its importance in multiple cellular processes, NKIRAS2 is still an enigmatic protein. little is known about its specific functions, or how it can be targeted as a drug or biomarker.

One way to target NKIRAS2 is through its role in the regulation of cell signaling. NKIRAS2 has been shown to play a role in the regulation of multiple cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell proliferation , differentiation, and survival, and is a key target for a number of drugs, including anti-cancer agents.

Another way to target NKIRAS2 is through its role in the regulation of the nervous system. NKIRAS2 has been shown to play a role in the development and maintenance of neural stem cells, by regulating the production of BDNF-尾 (BDNF) and nestin . BDNF is a protein that plays a key role in the development and maintenance of neural stem cells, and is often used as a target for drugs that promote stem cell proliferation.

NKIRAS2 has also been shown to play a role in the regulation of stress response, by activating the transcription factor-kappa-B (TKB). TKB is a key regulator of the stress response, and is involved in the regulation of cellular stress responses, including the expression of genes involved in stress-induced cellular responses.

In conclusion, NKIRAS2 is a protein that has been identified based on its conserved catalytic domain and unique N-terminus. It has been shown to play a role in the regulation of multiple cellular signaling pathways, including the TGF-β pathway, the development and maintenance of neural stem cells, and the regulation of stress response. While more research is needed to fully understand the functions of NKIRAS2, its potential as a drug target or biomarker is an exciting area of 鈥嬧?媟esearch.

Protein Name: NFKB Inhibitor Interacting Ras Like 2

Functions: Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and nuclear localization of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP- and GDP-bound forms block phosphorylation of NFKBIB (By similarity)

The "NKIRAS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NKIRAS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets